Home / Health / New Georgia Law to Boost Sickle Cell Treatment
New Georgia Law to Boost Sickle Cell Treatment
8 Apr
Summary
- Georgia House Bill 334 expands sickle cell treatment access.
- Medicaid coverage for emerging sickle cell treatments will be reviewed.
- The bill includes a public health education component on RSV for children.
Georgia is on the verge of a significant advancement in sickle cell disease care as House Bill 334, the "Sickle Cell Disease Protection Act," awaits Governor Kemp's signature. Passed on the final day of the 2026 legislative session, this bill is designed to enhance treatment access and update care for approximately 15,000 state residents. The legislation requires the Georgia Department of Community Health to conduct annual reviews of new sickle cell treatments, ensuring that Medicaid coverage evolves with medical progress.
Authored by State Rep. Omari Crawford, the bill also includes a vital public health education element. Childcare centers will be mandated to provide parents with information about Respiratory Syncytial Virus (RSV), a virus that can pose serious risks to children with pre-existing conditions like sickle cell disease. This legislative action comes as medical innovation, including potential gene therapies, rapidly advances, though access remains a significant barrier, particularly for Medicaid beneficiaries.
